Form CERTNAS - Certification by the Nasdaq Stock Market approving securities for listing:
SEC Accession No. 9999999997-15-014056
Filing Date
2015-10-08
Accepted
2015-10-13 09:18:53
Documents
1
Effectiveness Date
2015-10-08

Document Format Files

Seq Description Document Type Size
1 AUTO-GENERATED PAPER DOCUMENT 9999999997-15-014056.paper CERTNAS 294
  Scanned paper document scanned.pdf   43982
  Complete submission text file 9999999997-15-014056.txt   1352
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CERTNAS | Act: 34 | File No.: 001-13341 | Film No.: 15008132
SIC: 2836 Biological Products, (No Diagnostic Substances)